These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 32012718)

  • 21. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
    Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
    Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor signaling pathways.
    Kawasaki T; Kawai T
    Front Immunol; 2014; 5():461. PubMed ID: 25309543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.
    Wang JQ; Jeelall YS; Ferguson LL; Horikawa K
    Front Immunol; 2014; 5():367. PubMed ID: 25132836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Important aspects of Toll-like receptors, ligands and their signaling pathways.
    Chang ZL
    Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern recognitions receptors in immunodeficiency disorders.
    Mortaz E; Adcock IM; Tabarsi P; Darazam IA; Movassaghi M; Garssen J; Jamaati H; Velayati A
    Eur J Pharmacol; 2017 Aug; 808():49-56. PubMed ID: 28095323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors of the ascidian Ciona intestinalis: prototypes with hybrid functionalities of vertebrate Toll-like receptors.
    Sasaki N; Ogasawara M; Sekiguchi T; Kusumoto S; Satake H
    J Biol Chem; 2009 Oct; 284(40):27336-43. PubMed ID: 19651780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
    Gelman AE; Zhang J; Choi Y; Turka LA
    J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.
    Harada K; Isse K; Nakanuma Y
    J Clin Pathol; 2006 Feb; 59(2):184-90. PubMed ID: 16443736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy.
    Mikulandra M; Pavelic J; Glavan TM
    Curr Med Chem; 2017; 24(19):2011-2032. PubMed ID: 28322156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collaborative action of Toll-like and NOD-like receptors as modulators of the inflammatory response to pathogenic bacteria.
    Oviedo-Boyso J; Bravo-Patiño A; Baizabal-Aguirre VM
    Mediators Inflamm; 2014; 2014():432785. PubMed ID: 25525300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-Like Receptors (TLRs): The Role in Tumor Progression.
    Shcheblyakov DV; Logunov DY; Tukhvatulin AI; Shmarov MM; Naroditsky BS; Gintsburg AL
    Acta Naturae; 2010 Jul; 2(3):21-9. PubMed ID: 22649649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src Family Kinases Regulate Interferon Regulatory Factor 1 K63 Ubiquitination following Activation by TLR7/8 Vaccine Adjuvant in Human Monocytes and B Cells.
    Tulli L; Cattaneo F; Vinot J; Baldari CT; D'Oro U
    Front Immunol; 2018; 9():330. PubMed ID: 29545793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.